(19)
(11) EP 4 320 618 A2

(12)

(88) Date of publication A3:
29.12.2022

(43) Date of publication:
14.02.2024 Bulletin 2024/07

(21) Application number: 22785557.4

(22) Date of filing: 08.04.2022
(51) International Patent Classification (IPC): 
G16B 30/20(2019.01)
C12Q 1/6886(2018.01)
C12Q 1/6869(2018.01)
(52) Cooperative Patent Classification (CPC):
G16B 20/20; G16B 25/10; G16B 30/10; G16B 40/20; G16H 20/10; G16H 50/20
(86) International application number:
PCT/US2022/024082
(87) International publication number:
WO 2022/217096 (13.10.2022 Gazette 2022/41)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.04.2021 US 202163172590 P
05.11.2021 US 202163276378 P

(71) Applicant: Fred Hutchinson Cancer Center
Seattle, WA 98109 (US)

(72) Inventors:
  • HA, Gavin
    Seattle, Washington 98109 (US)
  • MACPHERSON, David
    Seattle, Washington 98109 (US)
  • NELSON, Peter S.
    Seattle, Washington 98109 (US)
  • DOEBLEY, Anna-Lisa
    Seattle, Washington 98109 (US)
  • HIATT, Joseph B.
    Seattle, Washington 98109 (US)
  • DE SARKAR, Navonil
    Seattle, Washington 98109 (US)
  • PATTON, Robert
    Seattle, Washington 98109 (US)

(74) Representative: MacLean, Martin Robert et al
Mathys & Squire
The Shard32 London Bridge StreetLondon SE1 9SG
The Shard32 London Bridge StreetLondon SE1 9SG (GB)

   


(54) CELL-FREE DNA SEQUENCE DATA ANALYSIS METHOD TO EXAMINE NUCLEOSOME PROTECTION AND CHROMATIN ACCESSIBILITY